CNMD vs AORT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 16, 2026

CNMD

34.7
AI Score
VS
CNMD Wins

AORT

32.3
AI Score

Investment Advisor Scores

CNMD

35score
Recommendation
SELL

AORT

32score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNMD AORT Winner
Revenue 242.09M 660.53M CNMD
Net Income -12.09M 36.90M CNMD
Gross Margin 64.4% 57.7% AORT
Net Margin -5.0% 5.6% CNMD
Operating Income -2.58M 61.82M CNMD
ROE -2.7% 3.5% CNMD
ROA -1.1% 1.6% CNMD
Total Assets 1.07B 2.30B CNMD
Current Ratio 3.47 1.48 AORT
Free Cash Flow -18.86M 44.74M CNMD

Relative Price Performance (Last 90 Days)

CNMD 1M: +23.7% · 3M: +38.0% AORT 1M: +12.3% · 3M: +23.3%

Current Technical Phase

CNMD

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (14.3% over 20 days), RSI 66

RSI (14): 66.0 · Price: $51.07

AORT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (10.1% over 20 days), RSI 57

RSI (14): 57.3 · Price: $28.08

Fundamentals Snapshot

Metric CNMD AORT
Market Cap
Forward P/E 10.7 35.9
Trailing P/E 27.8
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin 0.1% 0.1%
EPS 1.85 -0.06
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, CNMD is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.